SuVitas Holistic Healthcare is gearing up to raise Rs. 15 crore as it introduces the first dedicated transition care facility at Domlur in Bengaluru. The 60-bed post hospitalization rehabilitation center offers specialized programmes for stroke, head injuries, spinal cord injuries, hip-knee replacements and post cardiac procedures.
The Hyderabad-based start-up identified Bengaluru which is seen as a healthcare hub. Yet the city has been consistently falling short in providing quality follow-up care to manage of critical ailments.
Transition care serves a patient’s needs at 1/3rd cost of a hospital and 1/10th cost of critical care management and is therefore considered to be an affordable value addition to improve one’s QALY (Quality Adjusted Life Years).
Since 2015, SuVitas has fuelled a revolution in the country’s healthcare scene with its transition care, bringing together protocol-oriented personalised home-like environment through a multidisciplinary rehabilitation team comprising physicians, skilled nurses, physiotherapists, occupational therapists, speech therapists, clinical psychologists and dieticians.
According to Dr Vijay, director, New Initiatives, SuVitas said that considering the shortage of ICU beds in the city, insufficient trained rehab professionals and financial challenges to setup more critical care facilities, there is tremendous need for effective utilization of critical care services through transition care.
“Post-acute care is gaining greater relevance in today’s value-based care world. The growing base of non-local patients, increasing demand for long-term quality care for neuro cases, nuclear family culture and the flourishing medical tourism industry can significantly scale up the growth of segment. With transition care expected to grow to a 10,000 bed requirement in the near future,” said Sateesh Andra, Founder and Board Director, SuVitas.
Dr Harish Kalathil, director, operations, SuVitas confirmed the brand is ramping up its expansion plans and is looking at raising an expansion capital of Rs. 15 crore to launch two more centers in Mumbai and Chennai within 18 month’s time.
In our second stage of expansion, we are looking at raising an additional venture capital funding to expand to eight cities including Gurgaon, Chandigarh, Kochi and Coimbatore among others. With an impressive year-on-year growth rate, SuVitas reported a revenue growth of 140% in FY 2016 to FY 2017 and 50% from FY 2017 to FY 2018, he added.
Link: https://www.pharmabiz.com/NewsDetails.aspx?aid=109924&sid=2